Eradivir
Latest round
- Seed
Last raised
- Apr 2020
Total raised
- $0.1M
Investors
- 1
About Eradivir
Based in Indiana, Eradivir, Inc. specializes in developing innovative therapies targeting infectious diseases, particularly influenza, through advanced immunotherapy technologies. Eradivir, Inc. was founded in 2020 and is headquartered in West Lafayette, Indiana, US. The company is focused on creating treatments for influenza and other diseases based on its lead molecule, EV25. The founder, Philip Low, has a notable background in biomedical research and innovation. In October 2025, Eradivir, Inc. Eradivir's primary product is its lead molecule, EV25, designed to treat influenza by binding to diseased cells and enhancing immune responses. This molecule links infected cells to two anti-hapten antibodies, which helps the innate immune system to eliminate the virus effectively. The company's technology, known as Bispecific Antigenic immuno-Therapy (BAiT), aims to develop small molecule immunotherapies that may target a range of diseases, including viral infections and cancer, focusing on areas with high influenza prevalence. Eradivir generates revenue through the development and potential commercialization of its pharmaceutical products, specifically its flagship molecule, EV25. The company engages in strategic partnerships with healthcare providers, pharmaceutical distributors, and research institutions to distribute its therapies, structured around licensing deals and collaborations that enable interaction with hospitals, clinics, and research facilities essential for deploying their treatment options.
Who invested in Eradivir
1 investor across 1 round
See all investors in Eradivir
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 15, 2020
Amount
$0.1M
Investors
Questions about Eradivir
Who invested in Eradivir?
Eradivir has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eradivir raised?
Eradivir has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eradivir last raise money?
Eradivir's most recent round on record is a Seed, in Apr 2020.
What does Eradivir do?
Based in Indiana, Eradivir, Inc.
Where is Eradivir headquartered?
Eradivir is headquartered in West Lafayette, US.
Which VCs invest in companies like Eradivir?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eradivir's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Eradivir? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.